ICLR Stock Recent News

ICON PLC shares set higher lows in June, and the company presents strong fundamentals and economic earnings for shareholders. ICLR has shown robust financial performance, with a 9% YoY increase in revenue and a 200bps expansion in gross margin YoY. I reiterate ICLR as a buy, revising the price target to $304, and keeping the long-term $326 target.

DUBLIN--(BUSINESS WIRE)--ICON plc to Attend Upcoming Investor Conferences.

ICON Public Limited Company (ICLR) Q1 2023 Earnings Call Transcript.

Icon PLC (ICLR) came out with quarterly earnings of $2.90 per share, missing the Zacks Consensus Estimate of $2.98 per share. This compares to earnings of $2.76 per share a year ago.

ICON Public Limited Company (NASDAQ:ICLR ) Q4 2022 Earnings Conference Call February 23, 2023 8:00 AM ET Company Participants Kate Haven - VP of IR Brendan Brennan - CFO Steve Cutler - CEO Conference Call Participants Sandy Draper - Guggenheim Justin Bowers - Deutsche Bank Patrick Donnelly - Citi Eric Coldwell - Baird Casey Woodring - JPMorgan David Windley - Jefferies Elizabeth Anderson - Evercore Dan Leonard - Credit Suisse Jack Meehan - Nephron Research Derik De Bruin - Bank of America Operator Good day and thank you for standing by. Welcome to the ICON Q4 and Full Year 2022 Earnings Conference Call.

Icon PLC (ICLR) delivered earnings and revenue surprises of 2.29% and 0.44%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Icon PLC (ICLR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

ICON plc has set new highs after re-rating to the upside from late FY22. The company posted FY23E' guidance in January, where investors were swift to price in the growth forecasts.

DUBLIN--( BUSINESS WIRE )-- ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organisation, today announced that it will release its financial results for the fourth quarter 2022 after the market closes on Wednesday, February 22, 2023. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, February 23, 2023 at 8:00am ET.

DUBLIN, Ireland--( BUSINESS WIRE )--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023 at 5:15pm PST/ 8.15pm EST.